300 related articles for article (PubMed ID: 34505624)
1. Primary central nervous system lymphoma in a patient with neuropsychiatric systemic lupus erythematosus receiving mycophenolate mofetil: A case report and literature review.
Sakairi T; Nakasatomi M; Watanabe M; Hamatani H; Ikeuchi H; Kaneko Y; Handa H; Hiromura K
Mod Rheumatol Case Rep; 2022 Jan; 6(1):36-40. PubMed ID: 34505624
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-associated primary central nervous system lymphoma in a patient with diffuse cutaneous systemic sclerosis on long-term mycophenolate mofetil.
Chatterjee S; Angelov L; Ahluwalia MS; Yeaney GA
Joint Bone Spine; 2020 Mar; 87(2):163-166. PubMed ID: 31669807
[TBL] [Abstract][Full Text] [Related]
3. Diffuse large B-cell lymphoma of the central nervous system in mycophenolate mofetil-treated patients with systemic lupus erythematosus.
Tsang HH; Trendell-Smith NJ; Wu AK; Mok MY
Lupus; 2010 Mar; 19(3):330-3. PubMed ID: 19897521
[TBL] [Abstract][Full Text] [Related]
4. Primary central nervous system lymphoma in neuropsychiatric systemic lupus erythematosus: case-based review.
Ichikawa T; Shimojima Y; Kishida D; Kaneko T; Sekijima Y
Rheumatol Int; 2021 May; 41(5):1009-1017. PubMed ID: 32253501
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system lymphoma associated with mycophenolate mofetil in lupus nephritis.
Dasgupta N; Gelber AC; Racke F; Fine DM
Lupus; 2005; 14(11):910-3. PubMed ID: 16335585
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric Systemic Lupus Erythematosus with Cerebral Vasculitis and Lupus Nephritis Successfully Treated with High-dose Glucocorticoids and Mycophenolate Mofetil.
Tanaka S; Kawaguchi T; Kudo R; Kimura M; Rikitake Y; Iwao C; Rikitake M; Iwao K; Aizawa A; Kariya Y; Matsuda M; Miyauchi S; Takajo I; Umekita K
Intern Med; 2022 Oct; 61(20):3131-3135. PubMed ID: 35283391
[TBL] [Abstract][Full Text] [Related]
7. Fatal visceral disseminated varicella zoster infection during initial remission induction therapy in a patient with lupus nephritis and rheumatoid arthritis-possible association with mycophenolate mofetil and high-dose glucocorticoid therapy: a case report.
Habuka M; Wada Y; Kurosawa Y; Yamamoto S; Tani Y; Ohashi R; Ajioka Y; Nakano M; Narita I
BMC Res Notes; 2018 Mar; 11(1):165. PubMed ID: 29506558
[TBL] [Abstract][Full Text] [Related]
8. Development of primary central nervous system lymphoma in a systemic lupus erythematosus patient after treatment with mycophenolate mofetil and review of the literature.
Balci MA; Pamuk GE; Unlu E; Usta U; Pamuk ON
Lupus; 2017 Oct; 26(11):1224-1227. PubMed ID: 28152659
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus.
Kawazoe M; Kaneko K; Yamada Z; Masuoka S; Mizutani S; Yamada S; Shikano K; Sato H; Kaburaki M; Muraoka S; Kawai S; Nanki T
Clin Rheumatol; 2019 Jun; 38(6):1571-1578. PubMed ID: 30778862
[TBL] [Abstract][Full Text] [Related]
10. Primary central nervous system lymphoma in a patient with systemic lupus erythematosus mimicking high-grade glioma: A case report and review of literature.
Su L; Ding M; Chen L; Li C; Lao M
Medicine (Baltimore); 2018 Jun; 97(23):e11072. PubMed ID: 29879076
[TBL] [Abstract][Full Text] [Related]
11. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
Dittrich K; Ross S; Benz K; Amann K; Dötsch J
Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
[TBL] [Abstract][Full Text] [Related]
12. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
Sixdorf U; Bauer H; Märker-Hermann E
Dtsch Med Wochenschr; 2006 Oct; 131(41):2266-9. PubMed ID: 17036267
[TBL] [Abstract][Full Text] [Related]
13. Epstein‑Barr virus‑associated primary central nervous system lymphoma in an immunosuppressed patient with a comorbid autoimmune disorder: A case report.
Bricoune O; Kareem SS; Wallace G; Iacono DP; Macaulay R; Etame A; Pina Y; Robinson TJ; Mokhtari S
Exp Ther Med; 2023 Aug; 26(2):410. PubMed ID: 37522053
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric Systemic Lupus Erythematosus and Posterior Reversible Encephalopathy Syndrome in a Young Woman: A Case Report.
Mohammed Bawazir Y; Wasim Anshasi N
Curr Rheumatol Rev; 2023; 19(4):508-514. PubMed ID: 37078350
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil in neuropsychiatric systemic lupus erythematosus.
Jose J; Paulose BK; Vasuki Z; Danda D
Indian J Med Sci; 2005 Aug; 59(8):353-6. PubMed ID: 16129929
[TBL] [Abstract][Full Text] [Related]
16. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
Rathi M; Goyal A; Jaryal A; Sharma A; Gupta PK; Ramachandran R; Kumar V; Kohli HS; Sakhuja V; Jha V; Gupta KL
Kidney Int; 2016 Jan; 89(1):235-42. PubMed ID: 26489028
[TBL] [Abstract][Full Text] [Related]
17. Primary lymphoma of CNS, mycophenolate mofetil and lupus.
Finelli PF; Naik K; DiGiuseppe JA; Prasad A
Lupus; 2006; 15(12):886-8. PubMed ID: 17211996
[TBL] [Abstract][Full Text] [Related]
18. Secondary neuropsychiatric manifestations caused by Epstein-Barr virus encephalitis in a new onset systemic lupus erythematosus patient.
Hongbo C; Hongzhen M; Lingzhi H; Maosheng X; Mei C
Rheumatol Int; 2012 Aug; 32(8):2321-3. PubMed ID: 21607560
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
Choi CB; Won S; Bae SC
Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of vasculitis of the central nervous system in a patient with systemic lupus erythematosus.
Nikolov NP; Smith JA; Patronas NJ; Illei GG
Nat Clin Pract Rheumatol; 2006 Nov; 2(11):627-33; quiz 634. PubMed ID: 17075602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
